Beta Drugs Limited — Capecitabine Exporter Profile
Indian Pharmaceutical Exporter · #12 for Capecitabine · $708.5K export value · DGFT Verified
Beta Drugs Limited is the #12 Indian exporter of Capecitabine with $708.5K in export value and 124 verified shipments. Beta Drugs Limited holds a 0.8% market share in Capecitabine exports across 12 countries. The company exports 17 pharmaceutical products worth $7.8M across 5 therapeutic categories.
Beta Drugs Limited — Capecitabine Export Profile: Buyers & Destinations
Where Does Beta Drugs Limited Export Capecitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $254.3K | 33 | 35.9% |
| LEBANON | $178.9K | 32 | 25.3% |
| ETHIOPIA | $85.2K | 13 | 12.0% |
| PHILIPPINES | $75.5K | 10 | 10.7% |
| JORDAN | $29.0K | 4 | 4.1% |
| YEMEN, DEMOCRATIC | $29.0K | 4 | 4.1% |
| VENEZUELA | $22.0K | 16 | 3.1% |
| TANZANIA | $14.2K | 2 | 2.0% |
| MAURITIUS | $11.4K | 3 | 1.6% |
| NICARAGUA | $6.7K | 1 | 0.9% |
Beta Drugs Limited exports Capecitabine to 12 countries. The largest destination is MYANMAR accounting for 35.9% of Beta Drugs Limited's Capecitabine shipments, followed by LEBANON (25.3%) and ETHIOPIA (12.0%). These destinations reflect Beta Drugs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Capecitabine from Beta Drugs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AORTA COMPANY LIMITED | MYANMAR | $253.2K | 32 |
| EXPTRANS GMBH S.A.R.L. | LEBANON | $178.9K | 32 |
| TO THE ORDER OF | ETHIOPIA | $85.2K | 13 |
| ALSHAMELAH FOR TRADING | JORDAN | $58.0K | 8 |
| 2MG INCORPORATED | PHILIPPINES | $49.7K | 7 |
| 2 MG INCORPORATED | PHILIPPINES | $25.8K | 3 |
| HYPERPHARM LTD | MAURITIUS | $10.9K | 2 |
| GLOBAL CARE PHARMA CA | VENEZUELA | $10.0K | 3 |
| GLOBAL CARE PHARMA, C.A. | VENEZUELA | $10.0K | 12 |
| KAS MEDICS LIMITED | TANZANIA | $7.2K | 1 |
Beta Drugs Limited supplies Capecitabine to 19 buyers globally. The largest buyer is AORTA COMPANY LIMITED (MYANMAR), followed by EXPTRANS GMBH S.A.R.L. (LEBANON) and TO THE ORDER OF (ETHIOPIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Capecitabine Export Value and How Much Does Beta Drugs Limited Contribute?
India exported $32.0M worth of Capecitabine through 2,246 shipments from 216 suppliers to 123 countries, serving 516 buyers globally. Beta Drugs Limited contributes $708.5K to this total, accounting for 0.8% of India's Capecitabine exports. Beta Drugs Limited ships Capecitabine to 12 countries through 19 buyers.
What Is the Average Shipment Value for Beta Drugs Limited's Capecitabine Exports?
Beta Drugs Limited's average Capecitabine shipment value is $5.7K per consignment, based on 124 shipments totaling $708.5K. The largest destination is MYANMAR (35.9% of Beta Drugs Limited's Capecitabine exports).
How Does Beta Drugs Limited Compare to Other Indian Capecitabine Exporters?
Beta Drugs Limited ranks #12 among 216 Indian Capecitabine exporters with a 0.8% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($7.4M), INTAS PHARMACEUTICALS LIMITED ($5.0M), EUGIA PHARMA SPECIALITIES LIMITED ($4.0M). Beta Drugs Limited processed 124 shipments to 12 destination countries.
What Capecitabine Formulations Does Beta Drugs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CAPAD 500MG CAPECITABINE TABLETS USP 500 | $149.4K | 19 |
| CAPAD 500MG (CAPECITABINE 500MG TABLET) | $64.1K | 15 |
| CAPAD 500MG CAPECITABINE TABLETS USP 50 | $33.1K | 5 |
| CAPAD 500 MG CAPECITABINE TABLETS USP 500 MG BATCH: BT25083A, MFD: FEB-25,EXP: JAN-27 | $23.3K | 3 |
| CAPAD 500 MG CAPECITABINE TABLETS USP 500 MG BATCH: BT25084A, MFD: FEB-25,EXP: JAN-27 | $23.3K | 3 |
| CAPAD 500MG CAPECITABINE TABLETS USP 500MG BATCH NO BT23026A MFD 03 2023 EXP 02 2025 | $10.2K | 1 |
| CAPAD 500MG CAPECITABINE TABLETS USP 500MG BATCH NO BT23025A MFD 03 2023 EXP 02 2025 | $10.2K | 1 |
| CAPAD 500MG CAPECITABINE TABLETS USP 500MG BATCH NO BT23024A MFD 03 2023 EXP 02 2025 | $10.1K | 1 |
| CAPECITABINA 500MG CAPECITABINE TABLETSUSP 500MG BATCH: BT23290D MFD: OCT-23 EXP: SEP-25 | $10.0K | 3 |
| CAPAD 500 MG CAPECITABINE TABLETS USP (500 MG) BATCH: BT24077A, MFD: MAR-24, EXP: FEB-26 | $9.1K | 1 |
Beta Drugs Limited exports 75 distinct Capecitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CAPAD 500MG CAPECITABINE TABLETS USP 500 with 19 shipments worth $149.4K.
How Does Beta Drugs Limited Compare to Nearest Capecitabine Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | ALKEM LABORATORIES LIMITED | $1.2M | 24 | 1 | $50.0K |
| 10 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $946.4K | 27 | 5 | $35.1K |
| 12 | BETA DRUGS LIMITED ★ | $708.5K | 124 | 12 | $5.7K |
| 11 | DR REDDYS LABORATORIES LIMITED | $650.0K | 13 | 4 | $50.0K |
| 13 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | $599.5K | 17 | 3 | $35.3K |
Beta Drugs Limited ranks #12 among 216 Indian Capecitabine exporters. Average shipment value of $5.7K compared to the market average of $148.1K. The closest competitors by value are ALKEM LABORATORIES LIMITED and NAPROD LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Capecitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 359 | 16.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 283 | 12.6% |
| DELHI AIR CARGO ACC (INDEL4) | 233 | 10.4% |
| HYDERABAD ICD (INSNF6) | 173 | 7.7% |
| HYDERABAD AIR | 154 | 6.9% |
| DELHI AIR | 142 | 6.3% |
| HYDERABAD ACC (INHYD4) | 89 | 4.0% |
| Bombay Air | 80 | 3.6% |
What Other Advanced Oncology Products Does Beta Drugs Limited Export?
Beta Drugs Limited also exports these advanced oncology products. Each links to the detailed product page.
About Beta Drugs Limited
Beta Drugs Limited exports 17 products worth $7.8M. Beyond Capecitabine, top products include Linagliptin, Sitagliptin, Carboplatin, Mercaptopurine, Vildagliptin. View the complete Beta Drugs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Capecitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Capecitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Beta Drugs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 124 individual customs records matching Beta Drugs Limited exporting Capecitabine, covering 75 formulations to 12 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Capecitabine Export Data from Beta Drugs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Beta Drugs Limited's Capecitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Beta Drugs Limited
Full Company Profile →
17 products · $7.8M total trade · 5 categories
Capecitabine Stats
Company Overview
Top Products by Beta Drugs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Beta Drugs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Capecitabine. For current shipment-level data, contact TransData Nexus.